Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at different impeller agitation speeds

International Journal of Pharmaceutics

Volumn 403, Issue 1-2, 2011, Pages 1-14

  Bai, Ge ^a,b   Wang, Yimin ^a   Armenante, Piero M ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b MEDIMMUNE   (United States)

Author keywords

Agitation speed; Computational Fluid Dynamics (CFD); Dissolution testing; Hydrodynamics; Laser Doppler Velocimetry (LDV); Shear strain rate; USP Dissolution Testing Apparatus 2; Velocity profiles

Indexed keywords

ARTICLE; COMPUTATIONAL FLUID DYNAMICS; DISSOLUTION; FLOW RATE; LASER DOPPLER FLOWMETRY; MICROFLUIDICS; PRIORITY JOURNAL; SHEAR RATE; TABLET DISINTEGRATION; TABLET MACHINE; VELOCITY;

CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; LASER-DOPPLER FLOWMETRY; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOPOEIAS AS TOPIC; SHEAR STRENGTH; SOLUBILITY; SOLUTIONS; UNITED STATES;

EID: 78650169531     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.022     Document Type: Article

References (28)

1. G. Bai, P.M. Armenante, R.V. Plank, M. Gentzler, K. Ford, and P. Harmon Hydrodynamics investigation of USP dissolution test Apparatus 2 J. Pharm. Sci. 96 2007 2327 2349
2. G. Bai, P.M. Armenante, and R.V. Plank Experimental and computational determination of blend time in USP dissolution testing apparatus II J. Pharm. Sci. 96 2007 3072 3086
3. G. Bai, and P.M. Armenante Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II Pharm. Res. 25 2008 320 336
4. G. Bai, and P.M. Armenante Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing J. Pharm. Sci. 98 2009 1511 1531
5. J.L. Baxter, J. Kukura, and F.J. Muzzio Hydrodynamics-induced variability in the USP Apparatus 2 Dissolution Test Int. J. Pharm. 292 2005 17 28
6. R.B. Bird, E.W. Stewart, and N.F. Lightfoot Transport Phenomena 2002 John Wiley & Sons, Inc. New York
7. L.M. Bocanegra, G.J. Morris, J.T. Jurewicz, and J.W. Mauger Fluid and particle laser Doppler velocity measurements and mass transfer predictions for USP paddle method dissolution apparatus Drug Dev. Ind. Pharm. 16 1990 1441 1464
8. J.L. Cohen, B.B. Hubert, L.J. Leeson, C.T. Rhodes, J.R. Robinson, T.J. Roseman, and E. Shefter The development of USP dissolution and drug release standards Pharm. Res. 7 1990 983 987
9. P. Costa, and J.M.S. Lobo Influence of dissolution medium agitation on release profiles of sustained release tablets Drug. Dev. Ind. Pharm. 27 2001 811 817
10. D.C. Cox, and W.B. Furman Systematic error associated with Apparatus 2 of the USP dissolution test I: effects of physical alignment of the dissolution apparatus J. Pharm. Sci. 71 1982 451 452
11. D.C. Cox, W.B. Furman, and L.K. Thornton Systematic error associated with Apparatus 2 of the USP Dissolution Test III: limitation of calibrators and the USP suitability test J. Pharm. Sci. 72 1983 910 913
12. FDA, 1997. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms.
13. M.A. Fruitwala, P. Dondeti, E. Alkhawam, and S. Ahmed Rationales in the development of dissolution testing for solid oral dosage forms - an industrial, biopharmaceutical and regulatory perspective Clin. Res. Regul. Aff. 15 1998 187 207
14. M. Gibaldi, and S. Feldman Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms J. Pharm. Sci. 56 1967 1238 1242
15. M. Kamba, Y. Seta, N. Takeda, T. Hamaura, A. Kusai, H. Nakane, and K. Nishimura Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test Int. J. Pharm. 250 2003 99 109
16. H. Kortejärvi, J. Malkki, M. Marvola, A. Urtti, M. Yliperttula, and P. Pajunen Level A in vitro-in vivo correlation (IVIVC) model with bayesian approach to formulation series J. Pharm. Sci. 95 2006 1595 1605
17. J. Kukura, P.C. Arratia, E.S. Szalai, and F.J. Muzzio Engineering tools for understanding hydrodynamics of dissolution tests Drug Dev. Ind. Pharm. 29 2003 231 239
18. J. Kukura, J.L. Baxter, and F.J. Muzzio Shear distribution and variability in the USP Apparatus 2 under turbulent conditions Int. J. Pharm. 279 2004 9 17
19. J. Mauger, J. Ballard, R. Brockson, S. De, V. Gray, and D. Robinson Intrinsic dissolution performance of the USP dissolution apparatus 2 (rotating paddle) using modified salicylic acid calibration tablets: proof of principle Dissol. Technol. 10 2003 6 15
20. L. McCarthy, C. Kosiol, A.M. Healy, G. Bradley, J. Sexton, and O. Corrigan Simulating the hydrodynamic conditions in the United States pharmacopeias paddle dissolution apparatus AAPS Pharm. Sci. Technol. 4 2003
21. L. McCarthy, G. Bradley, J. Sexton, O. Corrigan, and A.M. Healy Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate mixing patterns and fluid velocities AAPS Pharm. Sci. Technol. 5 2004
22. T.W. Moore, J.F. Hamilton, and C.M. Kerner Dissolution testing: Limitation of USP prednisone and salicylic acid calibrator tablets Pharmacopeial Forum 21 1995 1387 1396
23. S.A. Qureshi, and I.J. McGilveray Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets ad a marketed drug (glibenclamide) product Eur. J. Pharm. Sci. 7 1999 249 258
24. S.A. Qureshi, and J. Shabnam Cause of high variability in drug dissolution testing and its impact on setting tolerances Eur. J. Pharm. Sci. 12 2001 271 276
25. S.A. Qureshi, and J. Shabnam Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products Eur. J. Pharm. Sci. 19 2003 291 297
26. M.S.F. Ross, and M. Rasis Mega paddle - a recommendation to modify apparatus 2 used in the USP general test for dissolution (711) Pharmacopeial Forum 24 1998 6351 6353
27. V.P. Shah, M. Gurbarg, A. Noory, S. Dighe, and J.P. Skelly Influence of higher rates of agitation on release patterns of immediate-release drug products J. Pharm. Sci. 81 1992 500 503
28. United States Pharmacopeia 31/National Formulary 26, 2008. General Chapter <711> Dissolution. 12601 Twinbrook Parkway, Rockville, MD 20852-1790, USA.